Effect of β-cell toxins on genetically engineered insulin-secreting cells

Journal of Autoimmunity

Volumn 10, Issue 3, 1997, Pages 239-244

  Tuch, Bernard E ^a   Beynon, Sandy ^a   Tabiin, Muhammad T ^a   Sassoon, Regina ^a   Goodman, Rebecca J ^a   Simpson, Ann M ^b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Diabetes; Gene therapy; Liver cell; Streptozotocin; cell

Indexed keywords

PENTAMIDINE; STREPTOZOCIN; TOXIN;

ANIMAL CELL; B LYMPHOCYTE ACTIVATION; CELL VIABILITY; CONFERENCE PAPER; DIABETES MELLITUS; DNA REPAIR; ENZYME SUBSTRATE; GENE THERAPY; GENETIC ENGINEERING; INSULIN RELEASE; LIVER CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS REGULATION;

EID: 0031170975     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0130     Document Type: Conference Paper

References (25)

1. Simpson A.M., Tuch B.E., Swan M.A., Tu J., Marshall G.M. Functional expression of the human insulin gene in a human hepatoma cell line (HEP G2). Gene Therapy. 2:1995;223-231.
2. Simpson A.M., Beynon S., Maxwell L., Tuch B.E., Marshall G.M. Dynamic insulin secretion and storage in a human hepatoma cell line - HEP G2ins/g. Diabetes. 45, Supp 2:1996;27A-27A.
3. Yamamoto H., Uchigata Y., Okamoto H. Streptozotocin and alloxan induce DNA strand breaks and alloxan and poly (ADP-ribose) synthetase in pancreatic islets. Nature. 294:1981;284-286.
4. 22. Diabetes. 40:1991;1141-1145.
5. Wilson G.L., Leiter E.H. Streptozotocin interactions with pancreatic β-cells and the induction of insulin-dependent diabetes. Current Topics in Microbiology Immunology. 1990;Springer Verlag, Berlin.
6. Saï P., Boillot D., Boitard Ch., Debray-Sachs M., Reach G., Assan R. Pentamidine, a new diabetogenic drug in laboratory rodents. Diabetologia. 25:1983;418-423.
7. Iwahashi H., Hanafusa T., Eguchi Y., Nakajima H., Miyagawa J., Itoh N., Tomita K., Namba M., Kuwajima M., Noguchi T., Tsujimoto Y., Matsuzawa Y. Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2. Diabetologia. 39:1996;530-536.
8. Pukel C., Baquerizo H., Rabinovitch A. Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-γ, tumour necrosis factor, lymphotoxin, and interleukin-1. Diabetes. 37:1988;133-136.
9. Hamaguchi K., Gaskins H.R., Leiter E.H. NIT-1, a pancreatic β-cell line established from a transgenic NOD/Lt mouse. Diabetes. 40:1991;842-849.
10. Tuch B.E., Turtle J.R., Simeonovic C.J. Streptozotocin is not toxic to the human fetal beta cell. Diabetologia. 32:1989;678-684.
11. Zhang H., Öllinger K., Brunk U. Insulinoma cells in culture show pronounced sensitivity to alloxan-induced oxidative stress. Diabetologia. 38:1995;635-641.
12. Janjic D., Wollheim C.B. Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay. Diabetologia. 35:1992;482-485.
13. Bank H.L. Assessment of islet cell viability using fluorescent dyes. Diabetologia. 30:1987;812-816.
14. Hintze J.L. Number Cruncher Statistical System. 1991.
15. Sibley R.K., Sutherland D.E.R. Pancreas transplantation: an immunohistologic and histopathologic examination of 100 grafts. Am. J. Pathol. 128:1987;151-170.
16. Segall M.D., Lafferty K.J., Kam I., Gill R.G. Effect of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation. 61:1996;1272-1274.
17. Tydén G., Reinholt F.P., Sundkvist G., Bolinder J. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N. Engl. J. Med. 335:1996;860-863.
18. Lipes M.A., Cooper E.M., Skelly R., Rhodes C.J., Boschetti E., Weir G.C., Davalli A.M. Insulin-secreting non-islet cells are resistant to autoimmune destruction. Proc. Natl. Acad. Sci. USA. 93:1996;8595-8600.
19. Sener A., Malaisse-Lagae F., Giroix M.-H., Malaisse W.J. Sensitivity to pentamidine but resistance to streptozotocin of tumoral insulin-producing cells (RINm5F) line. Pancreas. 1:1986;550-555.
20. Schnedl W.J., Ferber S., Johnson J.H., Newgard C.B. STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cell. Diabetes. 43:1994;1326-1333.
21. Mally M.I., Otonkoski T., Lopez A.D., Hayek A. Developmental gene expression in the human fetal pancreas. Pediatric Res. 36:1994;537-544.
22. Tuch B.E., Turtle J.R., Simeonovic C.J. Streptozotocin is not toxic to the human fetal beta cells. Diabetologia. 32:1989;678-684.
23. LeDoux S.P., Hall C.R., Forbes P.M., Patton N.J., Wilson G.L. Mechanisms of nicotinamide and thymidine protection from alloxan and streptozotocin toxicity. Diabetes. 37:1988;1015-1019.
24. Hoffman L., Mandel T.E., Carter W.M., Koulmanda M., Martin F.I.R. Insulin secretion by fetal human pancreas in organ culture. Diabetologia. 23:1982;426-430.
25. Sandler S., Welsh M., Andersson A. Nicotinamide does not protect islet B-cell metabolism against alloxan toxicity. Diabetes. 33:1984;937-943.